loadpatents
name:-0.031371116638184
name:-0.011499166488647
name:-0.00047898292541504
Ferguson; Mark William James Patent Filings

Ferguson; Mark William James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ferguson; Mark William James.The latest application filed is for "medicaments".

Company Profile
0.12.29
  • Ferguson; Mark William James - Furness Vale GB
  • Ferguson; Mark William James - Manchester GB
  • FERGUSON; Mark William James - Derbyshire GB
  • Ferguson; Mark William James - Stockport GB
  • Ferguson; Mark William James - High Peak GB
  • Ferguson; Mark William James - Cheshire GB
  • Ferguson; Mark William James - Furness Vale Perstsure GB
  • Ferguson, Mark William James - Skuupl Evczauo GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Medicaments
App 20150218222 - Ferguson; Mark William James ;   et al.
2015-08-06
Uses Of Mannose-6-phosphate
App 20120071425 - Ferguson; Mark William James ;   et al.
2012-03-22
Wnt3a For Inhibition Of Scarring
App 20110212897 - Ferguson; Mark William James ;   et al.
2011-09-01
Methods For Inhibition Of Scarring
App 20110166067 - Ferguson; Mark William James ;   et al.
2011-07-07
Methods For The Inhibition Of Scarring
App 20110152189 - Ferguson; Mark William James ;   et al.
2011-06-23
TGF-.beta.3 mutants
Grant 7,947,264 - Ferguson , et al. May 24, 2
2011-05-24
Methods And Systems For Determining Efficacy Of Medicaments
App 20110109651 - Fairlamb; David ;   et al.
2011-05-12
Tgf-beta3 Mutants
App 20110105396 - Ferguson; Mark William James ;   et al.
2011-05-05
Medicaments and Methods for Inhibition of Scarring
App 20110082171 - Ferguson; Mark William James ;   et al.
2011-04-07
Use Of Furin Convertase Inhibitors In The Treatment Of Fibrosis And Scarring
App 20110059896 - FERGUSON; Mark William James ;   et al.
2011-03-10
Medicaments and proteins based on TGF-.beta. monomers for the treatment of wounds
Grant 7,902,150 - Ferguson , et al. March 8, 2
2011-03-08
Protein folding
Grant 7,893,221 - Ferguson , et al. February 22, 2
2011-02-22
Methods For Inhibiting Scarring
App 20100266532 - FERGUSON; Mark William James
2010-10-21
Medicaments And Methods For Inhibition Of Non-ocular Scarring
App 20100204248 - Ferguson; Mark William James ;   et al.
2010-08-12
Method Of Prognosis
App 20100184610 - Ferguson; Mark William James ;   et al.
2010-07-22
Wound healing
App 20100152095 - Ferguson; Mark William James ;   et al.
2010-06-17
Method of promoting the healing of a chronic wound
Grant 7,727,520 - Ferguson June 1, 2
2010-06-01
Use of --furin--"convertase" inhibitors in the treatment of fibrosis and scarring
Grant 7,700,562 - Ferguson , et al. April 20, 2
2010-04-20
Method Of Prognosis
App 20100004140 - Ferguson; Mark William James ;   et al.
2010-01-07
Expression Of Tgf-beta In Plastids
App 20090328250 - Ferguson; Mark William James ;   et al.
2009-12-31
Method Of Diagnosis
App 20090305279 - Ferguson; Mark William James ;   et al.
2009-12-10
Method Of Diagnosis
App 20090280995 - Ferguson; Mark William James ;   et al.
2009-11-12
Protein Folding
App 20090181430 - Ferguson; Mark William James ;   et al.
2009-07-16
Data storage method
App 20090144299 - Ledwith; Ann Helena ;   et al.
2009-06-04
Medicaments And Proteins Based On Tgf-beta Monomers For The Treatment Of Wounds
App 20090137475 - Ferguson; Mark William James ;   et al.
2009-05-28
Proteins, Nucleic Acids And Medicaments
App 20090105146 - Ferguson; Mark William James ;   et al.
2009-04-23
Information Collection System
App 20080126478 - Ferguson; Mark William James ;   et al.
2008-05-29
Genetic polymorphism in the Zf9 gene linked to inappropriate scarring or fibrosis
Grant 7,332,305 - Ferguson , et al. February 19, 2
2008-02-19
Pharmaceutical composition containing inhibitors of interferon-gamma
App 20080031879 - Ferguson; Mark William James
2008-02-07
Pharmaceutical composition containing inhibitors of interferon-.gamma.
Grant 7,220,413 - Ferguson May 22, 2
2007-05-22
Use of convertase inhibitors in the treatment of fibrosis and scarring
App 20060052309 - Ferguson; Mark William James ;   et al.
2006-03-09
Wound healing
App 20050287139 - Ferguson, Mark William James ;   et al.
2005-12-29
Pharmaceutical composition containing inhibitors of interferon-gamma
App 20050158319 - Ferguson, Mark William James
2005-07-21
Pharmaceutical composition containing inhibitors of interferon-gamma
App 20040208871 - Ferguson, Mark William James
2004-10-21
Genetic testing
App 20040161761 - Ferguson, Mark William James ;   et al.
2004-08-19
Pharmaceutical composition
Grant 6,566,339 - Ferguson , et al. May 20, 2
2003-05-20
Wound healing
App 20020187149 - Ferguson, Mark William James ;   et al.
2002-12-12
Wound healing and treatment of fibrotic disorders
Grant 6,331,298 - Ferguson , et al. December 18, 2
2001-12-18
Mannose-6-phosphate composition and its use in treating fibrotic disorders
Grant 6,093,388 - Ferguson July 25, 2
2000-07-25
Wound healing
Grant 5,972,335 - Ferguson , et al. October 26, 1
1999-10-26
Anti-scarring compositions comprising growth factor neutralizing antibodies
Grant 5,662,904 - Ferguson , et al. September 2, 1
1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed